Insulin Management for Post-Kidney Transplant Patients

NPH Insulin Dosing for Steroid-Induced Hyperglycemia

Start NPH at 0.3-0.4 units/kg for patients on high-dose glucocorticoids, which equals 33-44 units for a patient with a body mass, according to the American Diabetes Association 1, 2
Administer the entire NPH dose in the morning to match the peak hyperglycemic effect of methylprednisolone, which occurs 4-8 hours after administration, as recommended by the American Diabetes Association 1, 2

Decrease Lantus from 8 units to 6-7 units daily (approximately 20-25% reduction) for patients with severe renal impairment, as recommended by the Kidney Disease: Improving Global Outcomes (KDIGO) consensus and the American Diabetes Association (ADA) 3, 4
Patients with severely impaired kidney function have markedly decreased insulin clearance and impaired renal gluconeogenesis, substantially increasing hypoglycemia risk, according to the ADA/KDIGO consensus 3, 4

Start with 1 unit of rapid-acting insulin for every 8-10 grams of carbohydrate, as recommended by the American Diabetes Association 2
For meals with the greatest postprandial glucose excursions (typically lunch when steroids peak), consider a more aggressive ratio of 1:6, according to the American Diabetes Association 2

Use the "1800 rule" as starting point: correction factor of 1 unit per 20-25 mg/dL above target, as recommended by the American Diabetes Association 2
Recommended correction scale:

Monitor blood glucose every 4-6 hours initially while adjusting therapy, as recommended by the American Diabetes Association 2
Target blood glucose 100-180 mg/dL for post-transplant patients, according to the American Diabetes Association 2

Reduce NPH dose by 10-20% for each significant decrease in steroid dose, as recommended by the American Diabetes Association 1, 2

Kidney transplant recipients have increased insulin resistance from immunosuppressive medications (tacrolimus is 5 times more diabetogenic than cyclosporine) combined with steroids, according to Diabetes Care 6
Oral agents like metformin and sulfonylureas are contraindicated with severely impaired kidney function due to lactic acidosis and hypoglycemia risk, as recommended by the Kidney Disease: Improving Global Outcomes (KDIGO) consensus and Diabetes Care 3, 5, 7

Morning NPH administration allows better monitoring during waking hours and reduces undetected nocturnal hypoglycemia risk, as recommended by the American Diabetes Association 4
Prescribe glucagon for emergent hypoglycemia, particularly important for patients with severely impaired kidney function, according to the American Diabetes Association 4